400 Mg Glives
400 Mg Glives

400 Mg Glives

MOQ : 1 Vial

400 Mg Glives Specification

  • Dosage Form
  • Tablet
  • Salt Composition
  • Imatinib Mesylate 400 mg
  • Indication
  • Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST)
  • Enzyme Types
  • Not applicable (Non-enzymatic pharmaceutical tablet)
  • Feature
  • High purity, effective for target indications, manufactured under GMP guidelines
  • Ingredients
  • Imatinib Mesylate, Excipients
  • Application
  • Oncology, Anti-cancer therapy
  • Physical Color/Texture
  • Light orange to orange, round, film-coated tablet
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store below 30C, protect from moisture and light
  • Shelf Life
  • 24 months
  • Batch Number
  • Printed on package
  • Packaging Type
  • Blister pack
  • Administration Route
  • Oral
  • MRP (Maximum Retail Price)
  • As per pack
  • Warning/Precaution
  • To be used only under medical supervision. Contraindicated in pregnancy and lactation unless necessary.
  • Prescription/OTC Status
  • Prescription only
  • Patient Population
  • Adults and pediatric patients as prescribed
  • ATC Code
  • L01XE01
  • Brand Name
  • Glivec (Glives 400 Mg)
  • Marketed Strength
  • 400 mg
  • Packaging Size
  • 10 tablets per strip
 
 

About 400 Mg Glives



Glivec (Glives 400 Mg) offers first-rate access to masterful oncology therapy, marked by its high purity and effective anti-cancer action. Each blister pack contains 10 decorated, light orange, film-coated tablets, each holding 400 mg of Imatinib Mesylate. Scarce in supply and only available by prescription, these round tablets are manufactured under strict GMP guidelines. Add to Cart for immediate benefit in managing Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). MRP is printed on the package, and the batch number guarantees authenticity. Usage is restricted under medical supervision, with contraindications for pregnancy and lactation unless necessary.

Versatile Application & Material Feature

Glives 400 mg extends its therapeutic reach beyond CML and GIST, supporting a diverse range of oncology applications as prescribed by healthcare professionals. Crafted from high-quality Imatinib Mesylate and excipients, each tablet delivers optimal purity, making it a preferred choice for adult and pediatric patients. The film-coated, decorated tablets are designed for consistent efficacy and dependable results, ensuring compatibility with advanced anti-cancer treatment protocols in varied clinical settings.


Sample, Export Markets, and Transportation Proposals

Samples of Glives 400 mg are available for proposal evaluation to interested distributors and traders. The main export markets include Asia, Africa, and the Middle East, with transportation arranged via the designated FOB ports in India. Freight management is efficiently organized to ensure prompt and secure delivery, supporting seamless international trade of pharmaceutical products. Each shipment adheres to strict packaging and moisture protection standards throughout the process, guaranteeing optimal product integrity.


FAQ's of 400 Mg Glives:


Q: How should Glives 400 Mg be stored for maximum shelf life?

A: Glives 400 Mg should be stored below 30C in a dry, moisture-free environment and protected from direct light to maintain its efficacy throughout the shelf life of 24 months.

Q: What is the process to access Glives 400 Mg for treatment?

A: Glives 400 Mg can be accessed only through a valid medical prescription and should be taken under strict medical supervision. Supply is managed by authorized distributors, exporters, and traders.

Q: Where is Glives 400 Mg mainly exported and what are the transportation options?

A: Glives 400 Mg is mainly exported to Asia, Africa, and the Middle East. Freight is arranged via FOB Indian ports, ensuring secure transportation and compliance with packaging standards.

Q: What are the key benefits of using Glives 400 Mg for oncology therapy?

A: Key benefits include its masterful anti-cancer activity, high purity, and targeted efficacy for CML and GIST. It's a first-rate solution manufactured under GMP guidelines for reliable therapeutic outcomes.

Q: When should Glives 400 Mg not be used?

A: Glives 400 Mg is contraindicated in pregnancy and lactation unless absolutely necessary, and its use should always be overseen by a medical professional.

Q: How do I verify the authenticity of my Glives 400 Mg tablets?

A: Each blister pack carries the batch number and MRP details printed on the package, helping verify authenticity and compliance with safety standards.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Cancer Medicines Category

0.5 Mg Trametinib Tablets

0.5 Mg Trametinib Tablets

Price 48000 INR / Box

Minimum Order Quantity : 1 Box

Ingredients : Other , Trametinib, inactive excipients

Indication : Treatment of melanoma and certain types of solid tumors

Feature : Other, Oral use, convenient dosage, precisely measured strength

Salt Composition : Trametinib 0.5 mg

10 Mg Lenvatinib Capsules IP

10 Mg Lenvatinib Capsules IP

Price 2299 INR / Box

Minimum Order Quantity : 1 Box

Ingredients : Other , Lenvatinib Mesylate and excipients

Indication : Used in the treatment of thyroid cancer and certain other types of cancer

Feature : Other, Readily dissolves for rapid release of drug

Salt Composition : Lenvatinib 10 mg

500 Mg Capecitabine Tablets IP

500 Mg Capecitabine Tablets IP

Price 300 INR / Box

Minimum Order Quantity : 1 Box

Ingredients : Other , Capecitabine IP and excipients

Indication : Used in the treatment of colorectal cancer and breast cancer

Feature : Other, Filmcoated, easy to swallow

Salt Composition : Capecitabine 500 mg

50 Mg Dasatinib Tablets

50 Mg Dasatinib Tablets

Price 299 INR / Box

Minimum Order Quantity : 1 Box

Ingredients : Other , Dasatinib, Excipients

Indication : Treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL)

Feature : Other, Oral targeted therapy, potent tyrosine kinase inhibitor

Salt Composition : Dasatinib 50 mg



Back to top